{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:04:05Z","timestamp":1784653445382,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11046-020-00466-5","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:53:44Z","timestamp":1626353624000},"page":"685-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Candidaemia Mortality Has not Changed Over the Last 2\u00a0Decades in Brazil"],"prefix":"10.1007","volume":"185","author":[{"given":"Daiane F.","family":"Dalla Lana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego R.","family":"Falci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valberto","family":"Sanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio D.","family":"Jaskulski Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-5395","authenticated-orcid":false,"given":"Alessandro C.","family":"Pasqualotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/mmy\/myy118","volume":"57","author":"G Cuervo","year":"2018","unstructured":"Cuervo G, Garcia-Vidal C, Puig-Asensio M, Merino P, Vena A, Mart\u00edn-Pe\u00f1a A, et al. Usefulness of guideline recommendations for prognosis in patients with candidemia. Med Mycol. 2018;57:659\u201367.","journal-title":"Med Mycol"},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"e0221033","DOI":"10.1371\/journal.pone.0221033","volume":"22","author":"MAP Medeiros","year":"2019","unstructured":"Medeiros MAP, Melo APV, Bento AO, Souza LBFC, Neto FAB, Garcia JB, et al. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: a 6-year retrospective study. PLoS One. 2019;22:e0221033.","journal-title":"PLoS One"},{"key":"466_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","volume":"17","author":"AL Colombo","year":"2013","unstructured":"Colombo AL, Guimar\u00e3es T, Camargo LF, Richtmann R, Queiroz-Telles F, Salles MJC, et al. Brazilian guidelines for the management of candidiasis\u2014a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;17:283\u2013312.","journal-title":"Braz J Infect Dis"},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"7","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;7:19\u201337.","journal-title":"Clin Microbiol Infect"},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/cis021","volume":"54","author":"DR Andes","year":"2012","unstructured":"Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110\u201322.","journal-title":"Clin Infect Dis"},{"key":"466_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002530","author":"A Warris","year":"2019","unstructured":"Warris A, Pana ZD, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, et al. Etiology and outcome of candidemia in neonates and children in Europe: an 11-year multinational retrospective study. Pediatr Infect Dis J. 2019. https:\/\/doi.org\/10.1097\/INF.0000000000002530.","journal-title":"Pediatr Infect Dis J"},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/jac\/dkx445","volume":"73","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Montravers P, Cornely OA, et al. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead. J Antimicrob Chemother. 2018;73:i14\u201325.","journal-title":"J Antimicrob Chemother"},{"key":"466_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","volume":"38","author":"C Agnelli","year":"2019","unstructured":"Agnelli C, Valerio M, Bouza E, Vena A, Guinea J, Del Carmen M-J, et al. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era. Eur J Clin Microbiol Infect Dis. 2019;38:607\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"e13195","DOI":"10.1111\/tid.13195","volume":"14","author":"M Fern\u00e1ndez-Ruiz","year":"2019","unstructured":"Fern\u00e1ndez-Ruiz M, Cardozo C, Salavert M, Aguilar-Guisado M, Escol\u00e0-Verg\u00e9 L, Mu\u00f1oz P, et al. Candidemia in solid organ transplant recipients in Spain: epidemiological trends and determinants of outcome. Transpl Infect Dis. 2019;14:e13195.","journal-title":"Transpl Infect Dis"},{"key":"466_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bjid.2018.10.278","volume":"22","author":"M Nucci","year":"2018","unstructured":"Nucci M, Braga PR, Nou\u00e9r SA, Anaissie E. Time of catheter removal in candidemia and mortality. Braz J Infect Dis. 2018;22:455\u201361.","journal-title":"Braz J Infect Dis"},{"key":"466_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"466_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","volume":"29","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM\/ESICM\/ ACCP\/ATS\/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530\u20138.","journal-title":"Intensive Care Med"},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10096-015-2527-2","volume":"35","author":"R Murri","year":"2016","unstructured":"Murri R, Scoppettuolo G, Ventura G, Fabbiani M, Giovannenze F, Taccari F, et al. Initial antifungal strategy does not correlate with mortality in patients with candidemia. Eur J Clin Microbiol Infect Dis. 2016;35:187\u201393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/myc.12013","volume":"56","author":"MD Bergamasco","year":"2013","unstructured":"Bergamasco MD, Garnica M, Colombo AL, Nucci M. Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil. Mycoses. 2013;56:256\u201363.","journal-title":"Mycoses"},{"key":"466_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1469-0691.2006.01435.x","volume":"12","author":"CA Binelli","year":"2006","unstructured":"Binelli CA, Moretti ML, Assis RS, et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect. 2006;12:538\u201343.","journal-title":"Clin Microbiol Infect"},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bjid.2018.07.008","volume":"22","author":"PR Braga","year":"2018","unstructured":"Braga PR, Cruz IL, Ortiz I, Barreiros G, Nou\u00e9r SA, Nucci M. Secular trends of candidemia at a Brazilian tertiary care teaching hospital. Braz J Infect Dis. 2018;22:273\u20137.","journal-title":"Braz J Infect Dis"},{"key":"466_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/13693780500421476","volume":"44","author":"LR Brito","year":"2006","unstructured":"Brito LR, Guimar\u00e3es T, Nucci M, et al. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol. 2006;44:261\u20136.","journal-title":"Med Mycol"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/13693786.2012.698024","volume":"51","author":"AL Colombo","year":"2013","unstructured":"Colombo AL, Garnica M, Camargo LFA, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013;51:38\u201344.","journal-title":"Med Mycol"},{"key":"466_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jped.2016.05.007","volume":"93","author":"FA Motta","year":"2017","unstructured":"Motta FA, Dalla-Costa LM, Muro MD, et al. Risk factors for candidemia mortality in hospitalized children. J Pediatr (Rio J). 2017;93:165\u201371.","journal-title":"J Pediatr (Rio J)"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/j.ijid.2012.02.005","volume":"16","author":"T Guimar\u00e3es","year":"2012","unstructured":"Guimar\u00e3es T, Nucci M, Mendon\u00e7a JS, et al. Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis. 2012;16:e442\u2013447.","journal-title":"Int J Infect Dis"},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/mmy\/myx077","volume":"56","author":"GL Breda","year":"2018","unstructured":"Breda GL, Tuon FF, Meis JF. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study. Med Mycol. 2018;56:406\u201315.","journal-title":"Med Mycol"},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1590\/S1413-86702005000500009","volume":"9","author":"VR Aquino","year":"2005","unstructured":"Aquino VR, Lunardi LW, Goldani LZ, Barth AL. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil. Braz J Infect Dis. 2005;9:411\u20138.","journal-title":"Braz J Infect Dis"},{"key":"466_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13756-019-0534-2","volume":"8","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Wang Q, Zhu F, An Y. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control. 2019;8:89.","journal-title":"Antimicrob Resist Infect Control"},{"key":"466_CR25","doi-asserted-by":"publisher","first-page":"E1512","DOI":"10.3390\/jcm8101512","volume":"8","author":"C Ortega-Loubon","year":"2019","unstructured":"Ortega-Loubon C, Cano-Hern\u00e1ndez B, Poves-Alvarez R, Mu\u00f1oz-Moreno MF, Rom\u00e1n-Garc\u00eda P, Balb\u00e1s-Alvarez S, et al. The overlooked immune state in candidemia: a risk factor for mortality. J Clin Med. 2019;8:E1512.","journal-title":"J Clin Med"},{"key":"466_CR26","doi-asserted-by":"publisher","first-page":"e0153247","DOI":"10.1371\/journal.pone.0153247","volume":"11","author":"P Vergidis","year":"2016","unstructured":"Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One. 2016;11:e0153247.","journal-title":"PLoS One"},{"key":"466_CR27","first-page":"1522","volume":"70","author":"C Tascini","year":"2019","unstructured":"Tascini C, Bertolino G, Sozio E, Sbrana F, Ripoli A, Carmignani C. Antifungal Stewardship Programs and candidemia. Clin Infect Dis. 2019;70:1522\u20133.","journal-title":"Clin Infect Dis"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-020-00466-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-020-00466-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:56:48Z","timestamp":1699239408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-020-00466-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s11046-020-00466-5","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"A.C.P. has received research grants from Pfizer, Gilead, and MSD, all antifungal drug companies. He has also given paid talks or participated in advisory boards for Pfizer, Gilead, United Medical, Astellas, MSD, and IMMY. D.R.F has received payment for lectures, advisory boards and\/or travel reimbursements from TEVA, Pfizer, United Medical, and Gilead Sciences. All other authors: no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}